FDA approves rapid-acting inhaled insulin for children

MedicalXpress | juin 12, 2026

The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes.